MINDWALK HOLDINGS CORP
HYFTNASDAQTrading Snapshot
- Day Range
- $1.37 – $1.39
- 52-Week Range
- $0.99 – $2.99
- Volume
- $2.53B
- Avg Volume
- $2.03B
- Shares Outstanding
- 47.0M
- Next Earnings
- Oct 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $15M
- Last Q Revenue
- $4M
- P/E Ratio
- -5.3
- P/S Ratio
- 5.6x
- EPS (TTM)
- $-0.36
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.4%
Why Investors Own HYFT
- ✓High-growth profile — revenue up +32.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 44% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MINDWALK HOLDINGS CORP
HYFT
StockOtter · stockotter.spaceAbout MINDWALK HOLDINGS CORP
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure pred
Analyzing MindWalk (NASDAQ:HYFT) & 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ: TXG - Get Free Report) and MindWalk (NASDAQ: HYFT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of the
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates
MindWalk Holdings Corp. (HYFT) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.07 per share a year ago.
MindWalk Q1 Earnings Call Highlights
MindWalk NASDAQ: HYFT reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, as the company continued investing in commercialization of its ReefIQ biological-data platf
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for its fiscal 2027 first quarter ended July 31, 2026. The quar